Parenteral oestrogen in the treatment of prostate cancer: a systematic review
about
Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09).Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practice.The health and well-being of prostate cancer patients and male-to-female transsexuals on androgen deprivation therapy: a qualitative study with comments on expectations and estrogen.
P2860
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@ast
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@en
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@nl
type
label
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@ast
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@en
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@nl
prefLabel
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@ast
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@en
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@nl
P2093
P2860
P356
P1476
Parenteral oestrogen in the treatment of prostate cancer: a systematic review
@en
P2093
A J Eastwood
M K B Parmar
R E Langley
Z C Hodges
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604230
P407
P577
2008-02-12T00:00:00Z
P5875
P6179
1005936531